Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
Alastair M. McKee, Benjamin Kirkup, Matthew Madgwick, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103012-103012
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
Adrienn Sipos, Gyula Ujlaki, Edit Mikó, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 104
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 100
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 77
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy
Tianqun Lang, Runqi Zhu, Xiao Zhu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 51
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors
Maria Teresa Majorini, Mario P. Colombo, Daniele Lecis
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1439-1447
Open Access | Times Cited: 43
Field cancerization in breast cancer
Emanuela Gadaleta, Graeme J. Thorn, Helen Ross‐Adams, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 4, pp. 561-574
Open Access | Times Cited: 43
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 38
Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment
Huixin Wu, Sebanti Ganguly, Trygve O. Tollefsbol
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 35
Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
Julia D. Ransohoff, Victor Ritter, Natasha Purington, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Hypoxia-associated autophagy flux dysregulation in human cancers
Jiding Fu, Jie Lin, Zili Dai, et al.
Cancer Letters (2024) Vol. 590, pp. 216823-216823
Closed Access | Times Cited: 8
Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress
Zsanett Sári, Edit Mikó, Tündé Kovàcs, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2915-2915
Open Access | Times Cited: 46
The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone
Subhashis Pal, Daniel S. Perrien, Tetsuya Yumoto, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 27
Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
Wenhui Yu, Zhongyu Xie, Kai Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 24
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma
Lorella Tripodi, Sara Feola, Ilaria Granata, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107668-107668
Open Access | Times Cited: 14
Altered gut microbiome drives heightened pain sensitivity in a murine model of metastatic triple-negative breast cancer
Rajib Dutta
American Journal of Cancer Research (2024) Vol. 14, Iss. 1, pp. 274-299
Open Access | Times Cited: 5
Exploring the impact of gut microbiota and diet on breast cancer risk and progression
Nancy M. Y. Teng, Christopher A. Price, Alastair M. McKee, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 3, pp. 494-504
Open Access | Times Cited: 32
The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer
Tündé Kovàcs, Edit Mikó, Gyula Ujlaki, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 4, pp. 1223-1249
Open Access | Times Cited: 31
Local anesthetics elicit immune-dependent anticancer effects
Lucillia Bezu, Alejandra Wu Chuang, Allan Sauvat, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004151-e004151
Open Access | Times Cited: 21
The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
Martina Di Modica, Valeria Arlotta, Lucia Sfondrini, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes
Man Wang, Lei Zhang, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Training the microbiota to increase immune checkpoint blockade and to reduce toxicity
María Rescigno
European Journal of Immunology (2023) Vol. 53, Iss. 11
Open Access | Times Cited: 11
Bones and guts – Why the microbiome matters
Kelly F. Contino, Katherine L. Cook, Yusuke Shiozawa
Journal of bone oncology (2024) Vol. 44, pp. 100523-100523
Open Access | Times Cited: 4
Electro-antibacterial therapy (EAT) to enhance intracellular bacteria clearance in pancreatic cancer cells
Josie L. Duncan, Raffae N. Ahmad, Hunter Danesi, et al.
Bioelectrochemistry (2024) Vol. 157, pp. 108669-108669
Closed Access | Times Cited: 4
The Microbiome Matters: Its Impact on Cancer Development and Therapeutic Responses
In-Young Chung, Ji Hyun Kim, Ara Koh
The Journal of Microbiology (2024) Vol. 62, Iss. 3, pp. 137-152
Closed Access | Times Cited: 4
The immunoregulatory role of gut microbiota in the incidence, progression, and therapy of breast cancer
Kaiyang Xue, Jiawei Li, Ruijie Huang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top